BioCentury
ARTICLE | Clinical News

Cethrin: Phase IIb start

August 18, 2008 7:00 AM UTC

In 1Q09, Alseres will begin a double-blind, placebo-controlled, North American Phase llb trial (ALSE-C-01) in about 50 patients. The study was initially slated to begin in 1H08. The company has an exc...